Colombo M - Search Results

1

Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.

De Nicola S, Aghemo A, Rumi MG, Galmozzi E, Valenti L, Soffredini R, De Francesco R, Prati GM, D'Ambrosio R, Cheroni C, Donato MF, Colombo M. De Nicola S, et al. Among authors: colombo m. Hepatology. 2012 Feb;55(2):336-42. doi: 10.1002/hep.24683. Epub 2012 Jan 3. Hepatology. 2012. PMID: 21932415

2

Sustained suppression of hepatitis C virus by interferon and ribavirin in hemophilic patients not responding to interferon monotherapy.

Santagostino E, Rumi MG, Rivi M, Colombo M, Mannucci PM; Hepatitis Study Group of the Association of Italian Hemophilia Centers. Santagostino E, et al. Among authors: colombo m. Blood. 2002 Feb 1;99(3):1089-91. doi: 10.1182/blood.v99.3.1089. Blood. 2002. PMID: 11807019 Free article. Clinical Trial.

3

A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virus.

Santagostino E, Colombo M, Rivi M, Rumi MG, Rocino A, Linari S, Mannucci PM; Study Group of the Association of Italian Hemophilia Centers. Santagostino E, et al. Among authors: colombo m. Blood. 2003 Jul 1;102(1):78-82. doi: 10.1182/blood-2002-10-3310. Epub 2003 Mar 20. Blood. 2003. PMID: 12649165 Free article.

4

Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.

Lampertico P, Del Ninno E, Viganò M, Romeo R, Donato MF, Sablon E, Morabito A, Colombo M. Lampertico P, et al. Among authors: colombo m. Hepatology. 2003 Apr;37(4):756-63. doi: 10.1053/jhep.2003.50148. Hepatology. 2003. PMID: 12668967 Clinical Trial.

5

Treatment of chronic hepatitis C in Europe.

Colombo M, Rumi MG, Ninno ED. Colombo M, et al. J Hepatobiliary Pancreat Surg. 2003;10(2):168-71. doi: 10.1007/s00534-002-0728-4. J Hepatobiliary Pancreat Surg. 2003. PMID: 14505151

6

Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapy.

Soffredini R, Rumi MG, Parravicini ML, Ronchi G, Del Ninno E, Russo A, Colombo M. Soffredini R, et al. Among authors: colombo m. Am J Gastroenterol. 2004 Sep;99(9):1738-43. doi: 10.1111/j.1572-0241.2004.30396.x. Am J Gastroenterol. 2004. PMID: 15330912

7

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.

Bruno S, Cammà C, Di Marco V, Rumi M, Vinci M, Camozzi M, Rebucci C, Di Bona D, Colombo M, Craxì A, Mondelli MU, Pinzello G. Bruno S, et al. Among authors: colombo m. J Hepatol. 2004 Sep;41(3):474-81. doi: 10.1016/j.jhep.2004.05.012. J Hepatol. 2004. PMID: 15336451 Clinical Trial.

8

Prevention of hepatocellular carcinoma.

Colombo M, Donato MF. Colombo M, et al. Semin Liver Dis. 2005;25(2):155-61. doi: 10.1055/s-2005-871195. Semin Liver Dis. 2005. PMID: 15918144 Free article. Review.

9

The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies.

Monti V, Aghemo A, Rumi MG, Donato MF, Del Ninno E, Colombo M. Monti V, et al. Among authors: colombo m. Antivir Ther. 2005;10(6):715-20. Antivir Ther. 2005. PMID: 16218170 Clinical Trial.

10

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

Lampertico P, Viganò M, Manenti E, Iavarone M, Lunghi G, Colombo M. Lampertico P, et al. Among authors: colombo m. Hepatology. 2005 Dec;42(6):1414-9. doi: 10.1002/hep.20939. Hepatology. 2005. PMID: 16317671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,557 results

Search Page

Filters